Upon learning of the NYSGC's rulings regarding the glaucine affair, I initially thought they handled it properly. They kept track of the positives but did nothing until research was conducted by various groups and the RMTC published standards. The consortium came up with guidelines of those testing between 100-499 pg/ml having to test below that level before racing again; 500- 999 pg/ml being disqualified; 1 ng/ml or more resulting in a fine and suspension being issued. Once the standard was published, the commission issued rulings resulting in one trainer being fined and suspended with others being disqualified.
But then, looking back, we see cases in Delaware and Maryland were handled differently. In those states, the commissions ruled the contamination was environmental, with no penalties to be assessed. Of course, their ruling came out in June, before the RMTC issued their advisory.
Was New York too harsh on those who came up with the glaucine positives or is it a case of the Delaware and Maryland racing commissions acting too quickly in dropping the positives on those horses which raced in those states?
I would likely side with Delaware and Maryland in this case. How do you penalize someone whose only crime may have been using the wrong bedding for their horses? Once it was known that glaucine is produced naturally in shavings from tulip poplar trees, the commission should have voided the positives up to that point and issued an advisory to the racing community advising them not to use those shavings in stalls; indicating penalties will be forthcoming on any future positives.
Regardless of which state you think handled the situation properly or not, it shows the problem of not having a nationalized medication policy.